1 | (1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide | - | - | - | - | [1] 11 11 💬 |
2 | 250 mg CK-2017357 | - | - | - | - | [2] 2 2, 11 💬 |
3 | 500 mg CK-2017357 | - | - | - | - | [2] 2 2, 11 💬 |
4 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬 | [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [26] 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
5 | Abatacept Injection | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬 | [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [2] 11 11, 46 💬 |
6 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [13] 11 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬 |
7 | Acetominofene | - | - | - | - | [2] 11 11, 63 💬 |
8 | ALN-CC5 | - | - | - | - | [4] 11 11, 62, 66, 109 💬 |
9 | Aluminium | [1] Aluminium Aluminium | - | - | - | [2] 11 11, 46 💬 |
10 | Aluminium hydroxide | [3] Aluminium Aluminium, Aluminum hydroxide, Hydroxide ion | [1] Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | [2] 11 11, 46 💬 |
11 | Aluminum | [1] Aluminium Aluminium | - | - | - | [1] 11 11 💬 |
12 | Aluminum hydroxide | [3] Aluminium Aluminium, Aluminum hydroxide, Hydroxide ion | [1] Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | [1] 11 11 💬 |
13 | ALXN1210 | - | - | - | - | [7] 2 2, 11, 13, 50, 62, 66, 109 💬 |
14 | ALXN1830 | - | - | - | - | [3] 11 11, 35, 61 💬 |
15 | ALXN2050 | - | - | - | - | [2] 11 11, 62 💬 |
16 | AMIFAMPRIDINA | - | - | - | - | [2] 3 3, 11 💬 |
17 | Amifampridina fosfato | - | - | - | - | [2] 3 3, 11 💬 |
18 | Amifampridine | [1] Amifampridine Amifampridine | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [3] 3 3, 11, 12 💬 |
19 | Amifampridine Phosphate | [2] Amifampridine Amifampridine, Phosphate ion | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [3] 3 3, 11, 12 💬 |
20 | Anti-C5 antibody | - | - | - | - | [4] 11 11, 14, 62, 109 💬 |
21 | Anti-Thymocyte Globulin | - | - | - | - | [18] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
22 | Apraclonidine | [1] Apraclonidine Apraclonidine | [1] Apraclonidine
Apraclonidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
23 | Apraclonidine Hcl 0.5% Oph Soln | [1] Apraclonidine Apraclonidine | [1] Apraclonidine
Apraclonidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
24 | ARGX-113 | - | - | - | - | [5] 11 11, 14, 35, 53, 63 💬 |
25 | ATG (rabbit) | [1] Rabbit Rabbit | - | - | - | [1] 11 11 💬 |
26 | AZA | - | - | - | - | [4] 11 11, 40, 96, 97 💬 |
27 | Azathioprine | [1] Azathioprine Azathioprine | [1] Azathioprine
Azathioprine
💬 | - | - | [21] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬 |
28 | B-peptide-CRM197 conjugate | [1] Corynebacterium diphtheriae CRM197 protein Corynebacterium diphtheriae CRM197 protein | - | - | - | [1] 11 11 💬 |
29 | Balance | [1] Isoxaflutole Isoxaflutole | - | - | - | [5] 6 6, 11, 46, 81, 149 💬 |
30 | Batoclimab | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬 | [1] FCGRT FCGRT 💬 | - | [2] 11 11, 14 💬 |
31 | Batoclimab 340 mg SC bi-weekly | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬 | [1] FCGRT FCGRT 💬 | - | [1] 11 11 💬 |
32 | Batoclimab 340 mg SC weekly | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬 | [1] FCGRT FCGRT 💬 | - | [2] 11 11, 14 💬 |
33 | Batoclimab 680 mg SC weekly | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬 | [1] FCGRT FCGRT 💬 | - | [1] 11 11 💬 |
34 | BBR 2778 | - | - | - | - | [2] 11 11, 13 💬 |
35 | BELIMUMAB | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬 | [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [13] 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬 |
36 | Benlysta (belimumab) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬 | [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [4] 11 11, 49, 53, 222 💬 |
37 | BENLYSTA® (belimumab) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬 | [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 11 11, 66, 222 💬 |
38 | Bexsero | [4] Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle, Neisseria meningitidis serogroup b fhbp fusion protein antigen, Neisseria meningitidis serogroup b nada protein antigen, Neisseria meningitidis serogroup b nhba fusion protein antigen | - | - | - | [6] 11 11, 13, 61, 62, 66, 222 💬 |
39 | BORTEZOMIB | [2] Bortezomib Bortezomib, Bortezomib D-mannitol | [1] Bortezomib
Bortezomib
💬 | [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [17] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 |
40 | Carmustine | [1] Carmustine Carmustine | [1] Carmustine
Carmustine
💬 | - | - | [5] 11 11, 13, 14, 28, 60 💬 |
41 | CD19-directed humanised afucosylated monoclonal antibody | - | - | - | - | [1] 11 11 💬 |
42 | CELLCEPT | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] Mycophenolate mofetil
Mycophenolate mofetil
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [5] 11 11, 13, 42, 43, 49 💬 |
43 | CellCept 500 mg | - | - | - | - | [1] 11 11 💬 |
44 | CellCept 500 mg film-coated tablets | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] Mycophenolate mofetil
Mycophenolate mofetil
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 💬 |
45 | CellCept 500 mg tablets | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] Mycophenolate mofetil
Mycophenolate mofetil
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 💬 |
46 | CellCept®500 mg tablets | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] Mycophenolate mofetil
Mycophenolate mofetil
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 💬 |
47 | Cemdisiran | [1] Cemdisiran Cemdisiran | - | - | - | [4] 11 11, 62, 66, 109 💬 |
48 | CFZ533 | - | - | - | - | [4] 11 11, 46, 49, 53 💬 |
49 | Chloride | [1] Chloride ion Chloride ion | - | - | - | [28] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬 |
50 | CLADRIBINE | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [3] 11 11, 13, 94 💬 |
51 | Cladrybine | - | - | - | - | [1] 11 11 💬 |
52 | Corynebacterium diphtheriae | [1] Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | [1] 11 11 💬 |
53 | CRM197 | [1] Corynebacterium diphtheriae CRM197 protein Corynebacterium diphtheriae CRM197 protein | - | - | - | [3] 11 11, 13, 46 💬 |
54 | CT103A cells | - | - | - | - | [2] 11 11, 13 💬 |
55 | CV-MG01 | [1] CV-MG01 CV-MG01 | - | - | - | [1] 11 11 💬 |
56 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬 |
57 | Cyclophosphamide and fludarabine | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 11 11, 13 💬 |
58 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
59 | Cytarabine | [1] Cytarabine Cytarabine | [1] Cytarabine
Cytarabine
💬 | - | - | [7] 11 11, 13, 14, 25, 49, 60, 65 💬 |
60 | DAS-001 | - | - | - | - | [1] 11 11 💬 |
61 | Descartes-08 | - | - | - | - | [1] 11 11 💬 |
62 | Difenidramina | - | - | - | - | [2] 11 11, 63 💬 |
63 | DIFENIDRAMINA CLORIDRATO | - | - | - | - | [3] 11 11, 19, 63 💬 |
64 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [1] Diphenhydramine
Diphenhydramine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [8] 11 11, 13, 49, 51, 70, 86, 222, 256 💬 |
65 | Diphenhydramine hydrochloride | [1] Diphenhydramine Diphenhydramine | [1] Diphenhydramine
Diphenhydramine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [2] 11 11, 49 💬 |
66 | ECULIZUMAB | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7] 11 11, 13, 14, 61, 62, 109, 222 💬 |
67 | EFALIZUMAB | [1] Efalizumab Efalizumab | [1] Efalizumab
Efalizumab
💬 | [1] ITGAL ITGAL 💬 | [12] Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [8] 11 11, 13, 37, 46, 53, 61, 95, 96 💬 |
68 | Efedrina | [1] Ephedrine Ephedrine | [1] Ephedrine
Ephedrine
💬 | [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
69 | Efgartigimod | - | - | - | - | [4] 11 11, 35, 53, 63 💬 |
70 | EFGARTIGIMOD ALFA | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬 | [1] FCGRT FCGRT 💬 | - | [6] 11 11, 14, 35, 53, 63, 162 💬 |
71 | Efgartigimod concentrate for solution for infusion 20 mg/mL | - | - | - | - | [1] 11 11 💬 |
72 | Efgartigimod IV | - | - | - | - | [1] 11 11 💬 |
73 | Efgartigimod PH20 SC | - | - | - | - | [5] 11 11, 14, 35, 63, 162 💬 |
74 | EN101 | - | - | - | - | [1] 11 11 💬 |
75 | Ephedrine | [1] Ephedrine Ephedrine | [1] Ephedrine
Ephedrine
💬 | [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
76 | EPHEDRINE HYDROCHLORIDE | [1] Ephedrine Ephedrine | [1] Ephedrine
Ephedrine
💬 | [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
77 | Etoposide | [1] Etoposide Etoposide | [1] Etoposide
Etoposide
💬 | [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [11] 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
78 | Famciclovir | [1] Famciclovir Famciclovir | [1] Famciclovir
Famciclovir
💬 | - | - | [2] 11 11, 13 💬 |
79 | Fc- and CDR-modified humanised monoclonal antibody against C5 | - | - | - | - | [3] 11 11, 62, 109 💬 |
80 | Firdapse | [1] Amifampridine Amifampridine | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 3 3, 11 💬 |
81 | FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | [1] Amifampridine Amifampridine | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 3 3, 11 💬 |
82 | Fludarabine | [1] Fludarabine Fludarabine | [1] Fludarabine
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [19] 11 11, 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 💬 |
83 | Fusion | [2] Iron polymaltose Iron polymaltose, Lactobacillus casei | [1] Lactobacillus casei
Lactobacillus casei
💬 | - | - | [7] 11 11, 13, 46, 49, 69, 70, 271 💬 |
84 | G-CSF | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬 | [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [16] 2 2, 6, 11, 13, 16, 22, 47, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
85 | GAMUNEX 10% | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 11 11 💬 |
86 | GB-0998 (Intravenous immunoglobulin) | - | - | - | - | [1] 11 11 💬 |
87 | Genotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms | - | - | - | - | [1] 11 11 💬 |
88 | Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) | - | - | - | - | [1] 11 11 💬 |
89 | GSK1550188 | - | - | - | - | [4] 11 11, 49, 66, 222 💬 |
90 | HBM9161 Injection (340 mg) | - | - | - | - | [1] 11 11 💬 |
91 | HBM9161 Injection (680mg and 340 mg) | - | - | - | - | [1] 11 11 💬 |
92 | HBM9161 Injection (680mg) | - | - | - | - | [1] 11 11 💬 |
93 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [12] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
94 | Hidrocloruro de efedrina | [1] Ephedrine Ephedrine | [1] Ephedrine
Ephedrine
💬 | [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
95 | HIZENTRA ® | - | - | - | - | [1] 11 11 💬 |
96 | Human normal immunoglobulin | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [9] 11 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
97 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 11 11, 14, 63, 65 💬 |
98 | Human normal immunoglobulin G (IgG) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 11 11 💬 |
99 | Hydroxide | [1] Hydroxide ion Hydroxide ion | - | - | - | [5] 11 11, 46, 96, 97, 284 💬 |
100 | IGIV-C | - | - | - | - | [1] 11 11 💬 |
101 | Immune globulin | - | - | - | - | [3] 11 11, 13, 14 💬 |
102 | Immune Globulin (Human), 10% Caprylate/Chromatography Purified | - | - | - | - | [1] 11 11 💬 |
103 | Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) | - | - | - | - | [1] 11 11 💬 |
104 | IMMUNOGLOBULIN G | - | - | - | - | [8] 2 2, 11, 13, 14, 49, 50, 63, 65 💬 |
105 | INEBILIZUMAB | [1] Inebilizumab Inebilizumab | [1] Inebilizumab
Inebilizumab
💬 | [1] CD19 CD19 💬 | [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [4] 11 11, 13, 51, 300 💬 |
106 | Influenza vaccine | - | - | - | - | [5] 11 11, 13, 46, 51, 84 💬 |
107 | Intravenous ImmuneGlobulin | - | - | - | - | [1] 11 11 💬 |
108 | Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬 |
109 | IVIG | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [7] 11 11, 13, 14, 17, 50, 51, 65 💬 |
110 | JNJ-80202135 | - | - | - | - | [4] 11 11, 46, 49, 53 💬 |
111 | Leflunomide | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬 | [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [12] 11 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300 💬 |
112 | M281 | - | - | - | - | [5] 11 11, 46, 49, 53, 61 💬 |
113 | M281 Injection | - | - | - | - | [1] 11 11 💬 |
114 | MabThera | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [22] 11 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
115 | Magnesium | [1] Magnesium Magnesium | - | - | - | [15] 6 6, 11, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
116 | Magnesium sulfate | [3] Magnesium Magnesium, Magnesium sulfate, Sulfate ion | [1] Magnesium sulfate
Magnesium sulfate
💬 | - | - | [3] 11 11, 296, 297 💬 |
117 | Melphalan | [1] Melphalan Melphalan | [1] Melphalan
Melphalan
💬 | - | - | [15] 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
118 | MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN | [2] Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | [1] 11 11 💬 |
119 | MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN | [2] Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | [1] 11 11 💬 |
120 | MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN | [2] Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | [1] 11 11 💬 |
121 | MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN | [2] Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | [1] 11 11 💬 |
122 | MENINGOCOCCAL GROUP Y OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (Â197) M8 (CRM197) PROTEIN | [2] Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | [1] 11 11 💬 |
123 | Menveo | [9] Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine, Meningococcal polysaccharide vaccine group A, Meningococcal polysaccharide vaccine group C, Meningococcal polysaccharide vaccine group W-135, Meningococcal polysaccharide vaccine group Y, Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen, Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen, Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen, Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen | [2] Meningococcal polysaccharide vaccine group A
Meningococcal polysaccharide vaccine group A
,
Meningococcal polysaccharide vaccine group C
💬 | - | - | [6] 11 11, 13, 61, 62, 66, 222 💬 |
124 | Mesna | [1] Coenzyme M Coenzyme M | - | - | - | [10] 11 11, 13, 44, 45, 51, 60, 65, 85, 96, 164 💬 |
125 | Mestinon | [1] Pyridostigmine Pyridostigmine | - | - | - | [3] 3 3, 6, 11 💬 |
126 | Methotrexate | [1] Methotrexate Methotrexate | [1] Methotrexate
Methotrexate
💬 | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬 |
127 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [1] Methylprednisolone
Methylprednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [46] 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
128 | Metilprdnisolone | - | - | - | - | [1] 11 11 💬 |
129 | METILPREDNISOLONE | - | - | - | - | [6] 11 11, 13, 53, 56, 63, 300 💬 |
130 | MG-O-1002 | - | - | - | - | [1] 11 11 💬 |
131 | MONARSEN | [1] Monarsen Monarsen | - | - | - | [1] 11 11 💬 |
132 | MONITOR | [1] Methamidophos Methamidophos | - | - | - | [4] 2 2, 11, 81, 129 💬 |
133 | MuSK-CAART | - | - | - | - | [1] 11 11 💬 |
134 | Mutagrip | - | - | - | - | [2] 11 11, 13 💬 |
135 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] Mycophenolic acid
Mycophenolic acid
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
136 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolic acid
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
137 | Mycophenolate mofetil (CellCept) | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolic acid
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [2] 11 11, 13 💬 |
138 | Mycophenolate mofetil [CellCept] | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolic acid
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 💬 |
139 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [1] Mycophenolic acid
Mycophenolic acid
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [8] 11 11, 43, 49, 51, 60, 66, 96, 222 💬 |
140 | N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO | - | - | - | - | [1] 11 11 💬 |
141 | N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE | [5] Aluminium Aluminium, Aluminum hydroxide, Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein, Hydroxide ion | [1] Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | [1] 11 11 💬 |
142 | Nipocalimab | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬 | [1] FCGRT FCGRT 💬 | - | [6] 11 11, 14, 46, 49, 53, 61 💬 |
143 | Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254measured as amount of total protein containing the PorA P1.4 | - | - | - | - | [1] 11 11 💬 |
144 | Oxaloacetate | [1] Oxaloacetic acid Oxaloacetic acid | - | - | - | [2] 6 6, 11 💬 |
145 | PARACETAMOLO | - | - | - | - | [9] 2 2, 11, 14, 19, 28, 53, 61, 63, 300 💬 |
146 | Phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [32] 2 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 💬 |
147 | PIXANTRONE | [1] Pixantrone Pixantrone | [1] Pixantrone
Pixantrone
💬 | [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [2] 11 11, 13 💬 |
148 | Placebo | - | - | - | - | [28] 3 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
149 | Pozelimab | [1] Pozelimab Pozelimab | [1] Pozelimab
Pozelimab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2] 11 11, 62 💬 |
150 | Pozelimab + Cemdisiran | [2] Cemdisiran Cemdisiran, Pozelimab | [1] Pozelimab
Pozelimab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬 |
151 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [42] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
152 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬 |
153 | Prednisone - Azathioprine | [2] Azathioprine Azathioprine, Prednisone | [2] Azathioprine
Azathioprine
,
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 11 11 💬 |
154 | Prednisone alone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 11 11, 66 💬 |
155 | PRIVIGEN | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 11 11, 14, 51, 65 💬 |
156 | PRN2246 | - | - | - | - | [2] 11 11, 13 💬 |
157 | Pyridostigmine | [1] Pyridostigmine Pyridostigmine | - | - | - | [4] 3 3, 6, 11, 256 💬 |
158 | Pyridostigmine, Prednisone, Tacrolimus | [3] Prednisone Prednisone, Pyridostigmine, Tacrolimus | [3] Tacrolimus
Tacrolimus
,
Prednisone
,
Tacrolimus
💬 | [6] NR3C1 NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [34] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
159 | Pyridostigmine, Tacrolimus | [2] Pyridostigmine Pyridostigmine, Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
160 | Rabbit | [1] Rabbit Rabbit | - | - | - | [8] 11 11, 13, 49, 51, 60, 65, 96, 285 💬 |
161 | Raptiva | [1] Efalizumab Efalizumab | [1] Efalizumab
Efalizumab
💬 | [1] ITGAL ITGAL 💬 | [12] Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [9] 11 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
162 | Raptiva 100 mg/ml powder and solvent for solution for injection | [1] Efalizumab Efalizumab | [1] Efalizumab
Efalizumab
💬 | [1] ITGAL ITGAL 💬 | [12] Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [7] 11 11, 13, 46, 53, 61, 95, 96 💬 |
163 | RAVULIZUMAB | [1] Ravulizumab Ravulizumab | [1] Ravulizumab
Ravulizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7] 2 2, 11, 13, 50, 62, 66, 109 💬 |
164 | RC18 160mg | - | - | - | - | [3] 11 11, 13, 66 💬 |
165 | RC18 240 mg | - | - | - | - | [2] 11 11, 53 💬 |
166 | RECOMBINANT NEISSERIA | - | - | - | - | [1] 11 11 💬 |
167 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E.COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE | [5] Aluminium Aluminium, Aluminum hydroxide, Hydroxide ion, Iron polymaltose, Lactobacillus casei | [2] Aluminum hydroxide
Aluminum hydroxide
,
Lactobacillus casei
💬 | - | - | [1] 11 11 💬 |
168 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN | - | - | - | - | [1] 11 11 💬 |
169 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN | [2] Iron polymaltose Iron polymaltose, Lactobacillus casei | [1] Lactobacillus casei
Lactobacillus casei
💬 | - | - | [2] 11 11, 13 💬 |
170 | REGN3918 | - | - | - | - | [2] 11 11, 62 💬 |
171 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48] 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
172 | Rituximab (Rituxan) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 11 11 💬 |
173 | Ro 533-3787/F01-06 | - | - | - | - | [1] 11 11 💬 |
174 | RO5333787 | - | - | - | - | [2] 11 11, 13 💬 |
175 | ROZANOLIXIZUMAB | [1] Rozanolixizumab Rozanolixizumab | [1] Rozanolixizumab
Rozanolixizumab
💬 | [1] FCGRT FCGRT 💬 | - | [3] 11 11, 14, 63 💬 |
176 | RTX | - | - | - | - | [5] 11 11, 46, 65, 222, 240 💬 |
177 | RVT-1401 | - | - | - | - | [2] 11 11, 61 💬 |
178 | Salbutamol | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 3 3, 11, 49, 85, 86, 111, 256, 299 💬 |
179 | Salbutamol 4Mg Tablet | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
180 | SALBUTAMOL SULFATE PH. EUR. | [2] Salbutamol Salbutamol, Sulfate ion | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
181 | Salbutamol WZF 4 mg | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
182 | SAR442168 | - | - | - | - | [2] 11 11, 13 💬 |
183 | SATRALIZUMAB | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [3] 11 11, 13, 86 💬 |
184 | Sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [20] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬 |
185 | Sodium Chloride solution | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [4] 11 11, 13, 51, 228 💬 |
186 | SOLIRIS | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7] 11 11, 13, 14, 61, 62, 109, 222 💬 |
187 | Subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬 |
188 | Subcutaneous immunoglobulins | - | - | - | - | [1] 11 11 💬 |
189 | Sulfate | [1] Sulfate ion Sulfate ion | - | - | - | [27] 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 💬 |
190 | Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 11 11 💬 |
191 | T-peptide-CRM197 conjugate | [1] Corynebacterium diphtheriae CRM197 protein Corynebacterium diphtheriae CRM197 protein | - | - | - | [1] 11 11 💬 |
192 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
193 | Tacrolimus capsule | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
194 | TAK-079 | - | - | - | - | [3] 11 11, 49, 63 💬 |
195 | TAK-079, TSF-021, TSF79 | - | - | - | - | [1] 11 11 💬 |
196 | Tetanus vaccin | - | - | - | - | [1] 11 11 💬 |
197 | Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [21] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
198 | Tocilizumab Injectable Product | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 11 11 💬 |
199 | Tofacitinib | [1] Tofacitinib Tofacitinib | [1] Tofacitinib
Tofacitinib
💬 | [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [15] 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬 |
200 | Tofacitinib 5 MG | [1] Tofacitinib Tofacitinib | [1] Tofacitinib
Tofacitinib
💬 | [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [4] 11 11, 40, 46, 271 💬 |
201 | Tolebrutinib | - | - | - | - | [2] 11 11, 13 💬 |
202 | Tolebrutininb | - | - | - | - | [1] 11 11 💬 |
203 | UCB7665 | - | - | - | - | [3] 11 11, 14, 63 💬 |
204 | Ultomiris | [1] Ravulizumab Ravulizumab | [1] Ravulizumab
Ravulizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [6] 2 2, 11, 13, 50, 62, 66 💬 |
205 | Ultomiris 1,100 mg/11 mL | [1] Ravulizumab Ravulizumab | [1] Ravulizumab
Ravulizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬 |
206 | Uplizna | [1] Inebilizumab Inebilizumab | [1] Inebilizumab
Inebilizumab
💬 | [1] CD19 CD19 💬 | [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [2] 11 11, 300 💬 |
207 | Velamox | - | - | - | - | [1] 11 11 💬 |
208 | Velcade | [2] Bortezomib Bortezomib, Bortezomib D-mannitol | [1] Bortezomib
Bortezomib
💬 | [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [3] 11 11, 28, 61 💬 |
209 | Velcade® | [2] Bortezomib Bortezomib, Bortezomib D-mannitol | [1] Bortezomib
Bortezomib
💬 | [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 11 11 💬 |
210 | Zilucoplan | [1] Zilucoplan Zilucoplan | [1] Zilucoplan
Zilucoplan
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 2 2, 11, 62 💬 |
211 | Zilucoplan (RA101495) | [1] Zilucoplan Zilucoplan | [1] Zilucoplan
Zilucoplan
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2] 11 11, 62 💬 |